Applied Therapeutics (APLT) Stock News Today: Cycle Deal Details, CVR Upside, and Analyst Outlook (Dec. 12, 2025)
NEW YORK — December 12, 2025 — Applied Therapeutics, Inc. is in the spotlight after announcing a definitive agreement to be acquired by Cycle Group Holdings Limited, a rare-disease-focused company that operates as Cycle Pharmaceuticals. The headline terms include a small upfront cash payment and a potentially meaningful contingent value right tied to future FDA approvals and sales milestones—setting up a high-volatility, event-driven setup for APLT stock as the market digests what’s “real” value versus what’s optionality. GlobeNewswire Below is a detailed roundup of what’s new as of 12/12/2025, why APLT stock moved, and how analysts are framing upside/downside.
